BrightSpring Health Services, Inc. logo

BrightSpring Health Services, Inc. (BTSG)

Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
60. 88
+1.54
+2.6%
$
11.51B Market Cap
- P/E Ratio
- Div Yield
1,826,185 Volume
- Eps
$ 59.34
Previous Close
Add Transaction
Day Range
59.52 61.02
Year Range
19.01 62.11
Want to track BTSG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Best Growth Stocks to Buy for March 9th

Best Growth Stocks to Buy for March 9th

BTSG, SANM and STX made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 9th, 2026.

Zacks | 2 months ago
Surging Earnings Estimates Signal Upside for BrightSpring Health Services, Inc. (BTSG) Stock

Surging Earnings Estimates Signal Upside for BrightSpring Health Services, Inc. (BTSG) Stock

BrightSpring Health Services, Inc. (BTSG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks | 3 months ago
Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?

Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?

Here is how BrightSpring Health Services, Inc. (BTSG) and C4 Therapeutics, Inc. (CCCC) have performed compared to their sector so far this year.

Zacks | 3 months ago
Best Growth Stocks to Buy for March 5th

Best Growth Stocks to Buy for March 5th

BTSG, HUBS and STX made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 5, 2026.

Zacks | 3 months ago
Here's Why Momentum in BrightSpring Health Services, Inc. (BTSG) Should Keep going

Here's Why Momentum in BrightSpring Health Services, Inc. (BTSG) Should Keep going

BrightSpring Health Services, Inc. (BTSG) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks | 3 months ago
New Strong Buy Stocks for March 5th

New Strong Buy Stocks for March 5th

STRL, HLIO, TBLA, BTSG and XP have been added to the Zacks Rank #1 (Strong Buy) List on March 5, 2026.

Zacks | 3 months ago
Best Momentum Stock to Buy for March 4th

Best Momentum Stock to Buy for March 4th

BTSG, XP and CPRX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 4, 2026.

Zacks | 3 months ago
Why Fast-paced Mover BrightSpring Health Services, Inc. (BTSG) Is a Great Choice for Value Investors

Why Fast-paced Mover BrightSpring Health Services, Inc. (BTSG) Is a Great Choice for Value Investors

BrightSpring Health Services, Inc. (BTSG) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks | 3 months ago
BTSG vs. CAI: Which Stock Is the Better Value Option?

BTSG vs. CAI: Which Stock Is the Better Value Option?

Investors with an interest in Medical Services stocks have likely encountered both BrightSpring Health Services, Inc. (BTSG) and Caris Life Sciences,?Inc. (CAI). But which of these two stocks presents investors with the better value opportunity right now?

Zacks | 3 months ago
BrightSpring Health Services, Inc. (BTSG) Q4 2025 Earnings Call Transcript

BrightSpring Health Services, Inc. (BTSG) Q4 2025 Earnings Call Transcript

BrightSpring Health Services, Inc. (BTSG) Q4 2025 Earnings Call Transcript

Seekingalpha | 3 months ago
BrightSpring Health Services, Inc. (BTSG) Q4 Earnings Lag Estimates

BrightSpring Health Services, Inc. (BTSG) Q4 Earnings Lag Estimates

BrightSpring Health Services, Inc. (BTSG) came out with quarterly earnings of $0.33 per share, missing the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.22 per share a year ago.

Zacks | 3 months ago
BrightSpring to Post Q4 Earnings: What's in Store for the Stock?

BrightSpring to Post Q4 Earnings: What's in Store for the Stock?

BTSG is set to report Q4 earnings with strong pharmacy growth, steady provider gains and improving margins.

Zacks | 3 months ago
Loading...
Load More